CFB and infection: To characterize the effect of Omicron breakthrough infection on the magnitude and breadth of serum neutralizing activity and BMEM cells, we studied blood samples from individuals that were double- or triple-vaccinated with BNT162b2, including cohorts that experienced breakthrough infection between November 2021 and mid-January 2022, a period when the BA.1 lineage was dominant in Germany (24).